HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Böhm Selected Research

Indicators and Reagents (Reagents)

11/2023Associations between baseline heart rate and blood pressure and time to events in heart failure with reduced ejection fraction patients: Data from the QUALIFY international registry.
11/2022Cardio-renal interaction - Clinical trials update 2022.
10/2017Heart rate and its reduction in chronic heart failure and beyond.
3/2016Assessing perinatal depression as an indicator of risk for pregnancy-associated cardiovascular disease.
7/2015Increased plant sterol deposition in vascular tissue characterizes patients with severe aortic stenosis and concomitant coronary artery disease.
3/2015Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease.
4/2014The Th17/Treg imbalance in patients with cardiogenic shock.
5/2013Heart rate and heart failure: the role of ivabradine therapy.
11/2012Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke.
6/2012Is heart rate a treatment target in heart failure?
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Böhm Research Topics

Disease

258Heart Failure
04/2024 - 02/2002
163Hypertension (High Blood Pressure)
04/2024 - 01/2002
45Cardiovascular Diseases (Cardiovascular Disease)
01/2024 - 02/2002
44Atrial Fibrillation
03/2024 - 06/2003
42Myocardial Infarction
10/2023 - 06/2002
40Coronary Artery Disease (Coronary Atherosclerosis)
04/2024 - 03/2002
37Fibrosis (Cirrhosis)
12/2023 - 02/2002
32Systolic Heart Failure
01/2023 - 11/2007
30Atherosclerosis
01/2021 - 12/2002
25Stroke (Strokes)
10/2023 - 06/2002
24Inflammation (Inflammations)
12/2023 - 07/2002
22Cardiogenic Shock
01/2021 - 08/2007
21Cardiomyopathies (Cardiomyopathy)
12/2023 - 10/2002
18Type 2 Diabetes Mellitus (MODY)
03/2024 - 03/2008
18Left Ventricular Dysfunction
04/2022 - 02/2002
16Shock
05/2024 - 03/2004
16Chronic Renal Insufficiency
04/2024 - 08/2013
15Hypertrophy
01/2022 - 09/2002
12Cardiomegaly (Heart Hypertrophy)
10/2022 - 02/2002
10Thrombosis (Thrombus)
10/2023 - 02/2003
10Vascular Diseases (Vascular Disease)
10/2023 - 08/2006
10Diabetes Mellitus
01/2018 - 10/2008
9Heart Diseases (Heart Disease)
04/2024 - 09/2002
9COVID-19
03/2024 - 12/2020
9Body Weight (Weight, Body)
08/2023 - 09/2002
9Erectile Dysfunction
01/2023 - 05/2003
9Hypotension (Low Blood Pressure)
11/2022 - 07/2010
9Coronary Disease (Coronary Heart Disease)
10/2017 - 03/2002
8Myocarditis (Carditis)
10/2022 - 01/2003
8Hemorrhage
01/2021 - 01/2008
8Infarction (Infarctions)
01/2021 - 02/2002
8Acute Coronary Syndrome
03/2017 - 02/2002
7Chronic Kidney Failure (Chronic Renal Failure)
11/2022 - 01/2009
6Ischemic Stroke
01/2023 - 06/2002
6Acute Kidney Injury (Acute Renal Failure)
01/2022 - 01/2008
6Dyslipidemias (Dyslipidemia)
01/2022 - 08/2009
6Ventricular Remodeling
01/2021 - 12/2004
6Atherosclerotic Plaque (Atheroma)
01/2020 - 05/2008
6Bradycardia
12/2016 - 09/2009
6Essential Hypertension
01/2016 - 01/2004

Drug/Important Bio-Agent (IBA)

47IvabradineIBA
10/2023 - 01/2007
38Antihypertensive Agents (Antihypertensives)IBA
02/2024 - 09/2010
35Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022 - 02/2002
26empagliflozinIBA
03/2024 - 01/2019
25Glucose (Dextrose)FDA LinkGeneric
12/2023 - 10/2007
25DiureticsIBA
09/2023 - 06/2003
24Biomarkers (Surrogate Marker)IBA
05/2024 - 01/2004
24Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
11/2022 - 01/2002
23salicylhydroxamic acid (SHAM)IBA
04/2024 - 03/2002
18Ramipril (Altace)FDA LinkGeneric
01/2021 - 02/2002
16Telmisartan (Micardis)FDA Link
01/2021 - 09/2006
16CholesterolIBA
12/2019 - 06/2002
14SodiumIBA
12/2023 - 12/2012
13Proteins (Proteins, Gene)FDA Link
12/2023 - 05/2002
13Mineralocorticoid Receptor AntagonistsIBA
09/2023 - 06/2009
12Rosuvastatin Calcium (Crestor)FDA Link
06/2014 - 06/2002
11Brain Natriuretic Peptide (Natrecor)FDA Link
03/2024 - 04/2007
11Indicators and Reagents (Reagents)IBA
11/2023 - 04/2009
11pro-brain natriuretic peptide (1-76)IBA
08/2023 - 05/2006
11CreatinineIBA
01/2023 - 11/2005
11dapagliflozinIBA
01/2022 - 11/2019
11LipidsIBA
01/2021 - 03/2002
10Sodium-Glucose Transport ProteinsIBA
03/2024 - 11/2019
10CollagenIBA
01/2020 - 03/2007
10NebivololFDA Link
01/2015 - 11/2002
9sacubitril and valsartan sodium hydrate drug combinationIBA
12/2023 - 04/2010
9Angiotensin Receptors (Angiotensin II Receptor)IBA
09/2023 - 09/2010
9Neprilysin (Neutral Endopeptidase)IBA
09/2023 - 01/2015
9Angiotensin Receptor AntagonistsIBA
11/2022 - 01/2002
9Natriuretic PeptidesIBA
10/2022 - 01/2015
9Messenger RNA (mRNA)IBA
01/2020 - 05/2002
9Angiotensin IIIBA
06/2010 - 03/2002
8Sodium-Glucose Transporter 2 InhibitorsIBA
12/2023 - 11/2019
8Eplerenone (Inspra)FDA LinkGeneric
11/2022 - 07/2010
8Reactive Oxygen Species (Oxygen Radicals)IBA
11/2021 - 04/2002
8ReninIBA
01/2021 - 02/2002
8AldosteroneIBA
10/2016 - 03/2002
7Apolipoproteins E (ApoE)IBA
10/2022 - 10/2006
7Paclitaxel (Taxol)FDA LinkGeneric
10/2020 - 10/2003
7aliskirenFDA Link
01/2018 - 11/2010
7Adrenergic Agents (Adrenergic Drugs)IBA
05/2013 - 03/2002
7erucylphosphocholineIBA
05/2011 - 01/2004
6omecamtiv mecarbilIBA
09/2023 - 11/2020
6AnticoagulantsIBA
06/2023 - 02/2008
6Interleukin-6 (Interleukin 6)IBA
07/2015 - 02/2002
6C-Reactive ProteinIBA
08/2014 - 02/2002
6Atrial Natriuretic Factor (ANF)IBA
03/2013 - 03/2002
5Triglycerides (Triacylglycerol)IBA
10/2023 - 08/2014

Therapy/Procedure

156Therapeutics
03/2024 - 01/2002
108Denervation
04/2024 - 12/2010
51Catheters
04/2024 - 05/2009
41Sympathectomy (Sympathectomies)
04/2024 - 12/2010
11Drug Therapy (Chemotherapy)
02/2023 - 08/2007
11Stents
07/2020 - 04/2003
10Patient Readmission
01/2022 - 06/2009
9Heart Transplantation (Grafting, Heart)
11/2021 - 08/2008
9Percutaneous Coronary Intervention
01/2021 - 01/2008
7Secondary Prevention
01/2024 - 04/2003
6Electrodes (Electrode)
05/2024 - 07/2005
6Aftercare (After-Treatment)
12/2016 - 09/2006